Stocks · Health care · Pharmaceutical Preparations

Evolus, Inc.

EOLS Clue Score45
United States Fiscal year ends December CIK 0001570562 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
David Moatazedi
2 Sep 2026
See Remarks
Sell
105,108
$9.04
$950.02K
Rui Avelar
20 Mar 2026
See Remarks
Sell
3,119
$4.75
$14.82K
David Moatazedi
16 Jun 2025
See Remarks
Sell
16,582
$9.89
$164.05K
David Moatazedi
13 Jun 2025
See Remarks
Sell
111,323
$10.05
$1.12M
Karah Herdman Parschauer
12 Mar 2025
Director
Sell
12,888
$12.99
$167.47K
Sandra Beaver
6 Sep 2024
Chief Financial Officer
Sell
3,276
$14.98
$49.07K
Tomoko Yamagishi-Dressler
30 Aug 2024
Chief Marketing Officer
Sell
5,631
$15.85
$89.25K
David Moatazedi
4 Jun 2024
See Remarks
Sell
140,214
$12.73
$1.78M
Vikram Malik
3 Jun 2024
Director
Sell
7,500
$12.96
$97.20K
David N Gill
14 May 2024
Director
Sell
6,718
$12.60
$84.65K
Vikram Malik
13 May 2024
Director
Sell
28,000
$12.93
$362.01K
David N Gill
13 May 2024
Director
Sell
3,643
$12.72
$46.36K
Sandra Beaver
10 May 2024
Chief Financial Officer
Sell
2,423
$12.72
$30.81K
Rui Avelar
10 May 2024
See Remarks
Sell
3,441
$12.72
$43.76K
David Moatazedi
10 May 2024
See Remarks
Sell
16,051
$12.72
$204.13K
David Moatazedi
27 Mar 2024
See Remarks
Sell
6,236
$13.86
$86.43K
David Moatazedi
19 Mar 2024
See Remarks
Sell
96,566
$13.92
$1.34M
Sandra Beaver
19 Mar 2024
Chief Financial Officer
Sell
5,672
$13.92
$78.98K
Rui Avelar
19 Mar 2024
See Remarks
Sell
27,603
$13.92
$384.35K
David Moatazedi
8 Dec 2023
See Remarks
Sell
31,300
$9.73
$304.51K
David Moatazedi
6 Dec 2023
See Remarks
Sell
51,348
$10.09
$517.89K
Medytox Inc.
16 Oct 2023
Former 10% Owner
Sell
1,690,663
$7.50
$12.68M
Rui Avelar
14 Mar 2023
See Remarks
Sell
14,906
$8.47
$126.24K
David Moatazedi
14 Mar 2023
See Remarks
Sell
64,211
$8.47
$543.80K
Alphaeon 1 LLC
17 Feb 2023
10% owner
Sell
1,850,000
$8.40
$15.54M
Medytox Inc.
7 Feb 2023
10% owner
Sell
2,187,511
$8.50
$18.59M
Medytox Inc.
20 Jan 2023
10% owner
Sell indirect
37,043
$11.04
$408.95K
Medytox Inc.
6 Oct 2022
10% owner
Sell
38,304
$8.99
$344.42K
Medytox Inc.
5 Oct 2022
10% owner
Sell
6,848
$8.95
$61.29K
Medytox Inc.
15 Sep 2022
10% owner
Sell
24,000
$10.34
$248.10K
Medytox Inc.
14 Sep 2022
10% owner
Sell
73,000
$10.27
$749.67K
Medytox Inc.
9 Sep 2022
10% owner
Sell
20,700
$10.53
$217.91K
Medytox Inc.
8 Sep 2022
10% owner
Sell
15,300
$10.39
$158.98K
Medytox Inc.
1 Aug 2022
10% owner
Sell
26,000
$13.28
$345.36K
Lauren P Silvernail
18 May 2022
See Remarks
Sell
52,015
$12.42
$646.03K
Lauren P Silvernail
17 May 2022
See Remarks
Sell
16,189
$13.92
$225.35K
David N Gill
16 May 2022
Director
Sell
5,000
$13.62
$68.08K
David Moatazedi
16 May 2022
See Remarks
Sell
55,321
$13.64
$754.31K
David N Gill
13 May 2022
Director
Sell
5,313
$13.10
$69.58K
David Moatazedi
28 Mar 2022
See Remarks
Sell
6,104
$11.62
$70.93K
Lauren P Silvernail
8 Mar 2022
See Remarks
Sell
10,192
$9.73
$99.12K
Rui Avelar
8 Mar 2022
See Remarks
Sell
10,192
$9.73
$99.12K
David Moatazedi
8 Mar 2022
See Remarks
Sell
37,972
$9.73
$369.29K
Crystal Muilenburg
8 Mar 2022
Chief Marketing Officer
Sell
6,495
$9.73
$63.17K
Alphaeon 1 LLC
2 Sep 2021
10% owner
Sell
2,597,475
$9.50
$24.68M
Vikram Malik
23 Aug 2021
Director
Sell indirect
26,077
$11.00
$286.72K
Vikram Malik
20 Aug 2021
Director
Sell indirect
49,878
$10.61
$529.32K
Vikram Malik
19 Aug 2021
Director
Sell indirect
11,962
$10.50
$125.56K
Vikram Malik
18 Aug 2021
Director
Sell indirect
25,000
$10.44
$261.01K
Vikram Malik
17 Aug 2021
Director
Sell indirect
42,083
$10.06
$423.55K
David Moatazedi
16 Aug 2021
See Remarks
Sell
47,737
$11.35
$541.74K
David Moatazedi
13 Aug 2021
See Remarks
Sell
22,708
$10.66
$242.07K
David Moatazedi
10 Aug 2021
See Remarks
Sell
41,763
$11.18
$466.84K
Crystal Muilenburg
10 Aug 2021
Chief Marketing Officer
Sell
5,362
$11.18
$59.94K
Rui Avelar
10 Aug 2021
See Remarks
Sell
14,293
$11.18
$159.79K
Lauren P Silvernail
10 Aug 2021
See Remarks
Sell
14,293
$11.18
$159.77K
David Moatazedi
25 Jan 2021
See Remarks
Sell
8,310
$7.46
$61.99K
Rui Avelar
25 Jan 2021
See Remarks
Sell
2,699
$7.46
$20.13K
Michael M. Jafar
25 Jan 2021
See Remarks
Sell
2,699
$7.46
$20.13K
Lauren P Silvernail
25 Jan 2021
See Remarks
Sell
2,699
$7.46
$20.13K
Rui Avelar
7 Jan 2020
See Remarks
Sell
39,442
$10.71
$422.28K
AEON Biopharma, Inc.
3 Jun 2019
10% owner
Sell
1,298,701
$19.25
$25.00M
Lauren P Silvernail
31 May 2019
See Remarks
Sell
2,612
$13.53
$35.35K
AEON Biopharma, Inc.
22 May 2019
10% owner
Sell
290,518
$19.25
$5.59M
AEON Biopharma, Inc.
20 May 2019
10% owner
Sell
1,017,422
$19.25
$19.59M
AEON Biopharma, Inc.
20 May 2019
10% owner
Sell
4,000,000
$19.25
$77.00M
AEON Biopharma, Inc.
29 Nov 2018
10% owner
Sell
573,888
$14.00
$8.03M
AEON Biopharma, Inc.
11 Sep 2018
10% owner
Sell
1,750,000
$21.04
$36.82M
AEON Biopharma, Inc.
23 Jul 2018
10% owner
Sell
1,000,000
$18.80
$18.80M

What was left out

Form 4 filings counted 224
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 2
Sales at will 69
Transactions with no price 0
Shares from compensation/vesting 15,064,534
Sales filed before the plan box existed 47
History held since 13 Feb 2018